Leo International Precision Health AG (LEOW) is executing a capital increase using funds from its company reserves. The move supports the company’s expansion of its AI-driven healthcare ecosystem, which integrates global healthcare services under a unified platform.
Leo International Precision Health AG is acquiring nine new assets across Asia and Europe to expand its AI-driven health solutions portfolio. The move aims to accelerate commercialization by integrating additional capabilities into its existing offerings. The company focuses on leveraging AI to enhance precision health diagnostics and treatments.
Leo International Precision Health AG announces plans to acquire nine companies in Asia and Europe to expand its inorganic growth strategy. The move targets regional markets to bolster its precision health offerings. The company aims to integrate these acquisitions to strengthen its operational footprint and service capabilities.
Leo International Precision Health AG publishes its 2025 financial results, marking a pivotal year in its development. The company, a holding entity building a global AI-driven healthcare ecosystem, lays the structural and operational groundwork for its growth strategy. The results reflect progress in establishing the foundation for its future AI-powered precision health platform.
Leo International Precision Health AG has approved a cash capital increase, excluding subscription rights. The move aims to strengthen the company’s financial flexibility without diluting existing shareholders’ stakes through subscription rights.